Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,

Slides:



Advertisements
Similar presentations
1 Epidemiologic Measures of Association Saeed Akhtar, PhD Associate Professor, Epidemiology Division of Epidemiology and Biostatistics Aga Khan University,
Advertisements

Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Cohort Studies.
Measures of Impact Dublin June Measures of Impact You want to reduce deaths from road traffic accidents Most impact for least cost Cohort study.
Unit 14: Measures of Public Health Impact.
Chance, bias and confounding
Understanding real research 3. Assessment of risk.
Epidemiology Practice. Epidemiology is the study of diseases in populations of humans or other animals, specifically how, when and where they occur, who.
Calculate Population Attributable Risk Percent Smoke YesNo Yes No I SM = 84 / 3000 = = 28.0 / 1000 I NS = 87 / 5000 =
Relative and Attributable Risks. Absolute Risk Involves people who contract disease due to an exposure Doesn’t consider those who are sick but haven’t.
Comunicación y Gerencia 22/12/20101Cohort studies.
Measures of association
Basic Elements of Testing Hypothesis Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology Director, Data Coordinating Center College.
Cohort Studies.
Principles of Epidemiology Lecture 9 Dona Schneider, PhD, MPH, FACE
COHORT STUDY DR. A.A.TRIVEDI (M.D., D.I.H.) ASSISTANT PROFESSOR
Cohort Studies Dr. Amna Rehana Siddiqui & Prof Awatif Alam Prof Ashry Gad Department of Family & Community Medicine September 2013.
HEAPHY 1 & 2 DIAGNOSTIC James HAYES Fri 30 th Aug 2013 Session 2 / Talk 4 11:33 – 12:00 ABSTRACT To estimate population attributable risks for modifiable.
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
How do cancer rates in your area compare to those in other areas?
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
Are exposures associated with disease?
Epidemiology Kept Simple
Analytic Epidemiology
Cohort Study.
INTRODUCTION TO EPIDEMIOLO FOR POME 105. Lesson 3: R H THEKISO:SENIOR PAT TIME LECTURER INE OF PRESENTATION 1.Epidemiologic measures of association 2.Study.
Multiple Choice Questions for discussion
Estimation of Various Population Parameters Point Estimation and Confidence Intervals Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology.
Measures of Association
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
How to Analyze Therapy in the Medical Literature (part 2)
The Impact of Epidemiology in Public Health Robert Hirokawa Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.
Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
S. Mazloomzadeh MD, PhD COHORT STUDIES Learning Objectives To develop an understanding of: - What is a cohort study? - What types of cohort studies are.
RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Measuring associations between exposures and outcomes
Basic concept of clinical study
The Impact of Epidemiology in Public Health Robert Hirokawa, DrPH Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.
EPIDEMIOLOGY The study of the distribution and determinants of health related states and events in specified population and application of this.
Coffee and Cardiovascular Disease
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Instructor Resource Chapter 17 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
COHORT STUDY COHORT A group of people who share a common characteristic or experience within a defined period of time. e.g. age, occupation, exposure.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Cohort Study Present: Disease Past: Exposure.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Headlines Introduction General concepts
Cohort Studies Dr Hayfa Wahbi, Dr. Amna Rehana Siddiqui & Department of Family & Community Medicine September 2015.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Epidemiological Study Designs And Measures Of Risks (1)
Measures of Association (2) Attributable Risks and fractions October Epidemiology 511 W. A. Kukull.
Instructional Objectives:
A Search For Better Health Topic 11: Epidemiology
Epidemiologic Measures of Association
بسم الله الرحمن الرحيم COHORT STUDIES.
Some Epidemiological Studies
Lecture 3: Introduction to confounding (part 1)
Epidemiology MPH 531 Analytic Epidemiology Cohort Studies
Measurements of Risk & Association …
Mpundu MKC MSc Epidemiology and Biostatistics, BSc Nursing, RM, RN
Measures of risk and association
Cohort and longitudinal studies: statistics
RISK ASSESSMENT, Association and causation
Risk Ratio A risk ratio, or relative risk, compares the risk of some health-related event such as disease or death in two groups. The two groups are typically.
Presentation transcript:

Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida, College of Nursing Professor, College of Public Health Department of Epidemiology and Biostatistics Associate Member, Byrd Alzheimer’s Institute Morsani College of Medicine Tampa, FL, USA 1

SECTION 7.1 Introduction to Meta-Analysis Meta analysis and measures of public health impact

SECTION 7.6 Introduction to Measures of Public Health Impact

Learning Outcome: Explain features of individual measures of public health impact.

Measures of Public Health Impact Attributable Risk (AR)Number Attributable Risk Percent (AR%)Percentage Population Attributable Risk (PAR)Number Population Attributable Risk Percent (PAR%)Percentage Number Needed to Treat (NNT)Number Number Needed to Harm (NNH)Number

Measures of Public Health Impact IMPORTANT! They all assume (require) that a cause-effect relationship exists between the exposure and the outcome.

Relative Risk vs. Attributable Risk Relative Risk:Measure of the strength of association, and indicator used to assess the possibility of a causal relationship. Attributable Risk:Measure of the potential for prevention of disease if the exposure could be eliminated (assuming a causal relationship).

Relative Risk vs. Attributable Risk Relative Risk: Etiology Attributable Risk: Policy decisions Funding decisions (e.g. prevention programs)

Attributable Risk: Refers to EXPOSED persons. Population Attributable Risk: Refers to both EXPOSED and NONEXPOSED persons. Measures of Public Health Impact

SECTION 7.7 Attributable Risk And Attributable Risk Percent

Learning Outcome: Calculate and interpret the measures attributable risk (AR) and attributable risk percent (AR%)

Attributable Risk (AR) Among the EXPOSED: How much of the disease that occurs can be attributed to a certain exposure? AR AR% This is of primary interest to the practicing clinician.

Attributable Risk (AR) AR = I exposed – I nonexposed = “Risk Difference” SmokeYesNo Yes No Develop CHD I SM = 84 / 3000 = = 28.0 / 1000 I NS = 87 / 5000 = = 17.4 / 1000 (background risk) AR = (28.0 – 17.4) / 1000 = 10.6 / 1000

Attributable Risk (AR) AR = (28.0 – 17.4) / 1000 = 10.6 / 1000 Among SMOKERS, 10.6 of the 28/1000 incident cases of CHD are attributed to the fact that these people smoke … Among SMOKERS, 10.6 of the 28/1000 incident cases of CHD that occur could be prevented if smoking were eliminated.

Practice - Attributable Risk (AR) Hypertension Among smokers, calculate and interpret incident cases of hypertension that are attributed to their smoking. Among SMOKERS, SmokingDiseaseNo DiseaseTotalIncidence (I)(I) per 1000 Exposed ________ Not Exposed ________ AR________ AR = I exposed – I nonexposed

Practice - Attributable Risk (AR) Hypertension Among smokers, calculate and interpret incident cases of hypertension that are attributed to their smoking. Among SMOKERS, 34.2 of the 130/1000 incident cases of hypertension are attributed to the fact that these people smoke … Among SMOKERS, 34.2 of the 130/1000 incident cases of hypertension that occur could be prevented if smoking were eliminated. SmokingDiseaseNo DiseaseTotalIncidence (I)(I) per 1000 Exposed Not Exposed AR AR = I exposed – I nonexposed AR = – = 0.034

Attributable Risk Percent (AR%) AR% = (I exposed – I nonexposed ) / I exposed = “Etiologic fraction” SmokeYesNo Yes No Develop CHD AR% = (28.0 – 17.4) / 28.0=37.9% I SM = 84 / 3000 = = 28.0 / 1000 I NS = 87 / 5000 = = 17.4 / 1000 (background risk)

Attributable Risk Percent (AR%) AR% = (28.0 – 17.4) / 28.0= 37.9% Among SMOKERS, 38% of the morbidity from CHD may be attributed to smoking… Among SMOKERS, 38% of the morbidity from CHD could be prevented if smoking were eliminated.

Practice - Attributable Risk Percent (AR%) Metabolic Syndrome Among heavy drinkers, calculate and interpret the percentage of incident cases of the metabolic syndrome attributed to their drinking. Among HEAVY DRINKERS, DrinkingDiseaseNo DiseaseTotalIncidence (I) Exposed _____ Not Exposed _____ AR%__________% AR% = (I exposed – I nonexposed ) / I exposed AR% =

Practice - Attributable Risk Percent (AR%) Metabolic Syndrome Among heavy drinkers, calculate and interpret the percentage of incident cases of the metabolic syndrome attributed to their drinking. Among HEAVY DRINKERS, 43.9% of the morbidity from the metabolic syndrome may be attributed to heaving drinking … Among HEAVY DRINKERS, 43.9% of the morbidity from the metabolic syndrome could be prevented if heavy drinking were eliminated. DrinkingDiseaseNo DiseaseTotalIncidence (I) Exposed Not Exposed AR% % AR% = (I exposed – I nonexposed ) / I exposed AR% = (0.119 – 0.067) / = x 100 = 43.9%

SECTION 7.8 Population Attributable Risk and Population Attributable Risk Percent

Learning Outcome: Calculate and interpret the measures population attributable risk (PAR) and population attributable risk percent (PAR%)

Population Attributable Risk (PAR) Among the EXPOSED and NONEXPOSED (e.g. total population): How much of the disease that occurs can be attributed to a certain exposure? PAR PAR% This of interest to policy makers and those responsible for funding prevention programs.

PAR and PAR% Example: We want to estimate how much of the burden of diabetes among Tampanians is attributed to obesity.

PAR and PAR% CAUTION! In order to calculate PAR and PAR%, we have to be reasonably sure that the results of the study can be generalized to the population of Tampa. (e.g the incidence rates drawn from the sample approximate the incidence rates in the entire population).

Population Attributable Risk (PAR) PAR = I total – I nonexposed WeightYesNo Obese Slim Diabetes I T = 1100 / = 0.11 = 110 / 1000 I NE = 250 / 5500 = = 45.5 / 1000 (background risk) PAR = (110 – 45.5) / 1000 = 64.5 /

Population Attributable Risk (PAR) PAR = (110 – 45.5) / 1000 = 64.5 / 1000 In Tampa, 64.5 of the 110/1000 incident cases of diabetes are attributed to obesity … In Tampa, 64.5 of the 110/1000 incident cases of diabetes that occur could be prevented with sufficient weight loss.

Practice – Population Attributable Risk (PAR) Hypertension Estimate how much of the burden of hypertension among Tampanians is attributed to high salt consumption. In TAMPA, Salt IntakeDiseaseNo DiseaseTotalIncidence (I) (I) per 1,000 _______ Exposed _______ Not Exposed _______ Total _______ PAR_______ PAR = (I total – I nonexposed ) PAR =

Practice – Population Attributable Risk (PAR) Hypertension Estimate how much of the burden of hypertension among Tampanians is attributed to high salt consumption. In TAMPA, of the 64.18/1,000 incident cases of hypertension are attributed to having high salt consumption. In TAMPA, of the 64.18/1,000 incident cases of hypertension could be prevented with elimination of high salt intake. Salt IntakeDiseaseNo DiseaseTotalIncidence (I) (I) per 1, /1, /1, /1,000 Exposed Not Exposed Total PAR /1,000 PAR = (I total – I nonexposed ) PAR = (0.064 – 0.051) / = per 1,000

Population Attributable Risk Percent PAR% = (I total – I nonexposed ) / I total WeightYesNo Obese Slim Diabetes PAR% = (110 – 45.5) / 110=58.6% I T = 1100 / = 0.11 = 110 / 1000 I NE = 250 / 5500 = = 45.5 / 1000 (background risk)

Population Attributable Risk Percent PAR% = (110 – 45.5) / 110= 58.6% In Tampa, 59% of the cases of diabetes may be attributed to obesity in the population… In Tampa, 59% of the cases of diabetes could be prevented if Tampa residents lost sufficient weight.

Practice – Population Attributable Risk% (PAR%) Hypertension Estimate the percentage of the burden of hypertension among Tampanians that is attributed to high salt consumption. In TAMPA, 21% of the cases of hypertension may be attributed to having high salt consumption in the population. In TAMPA, 21% of the cases of hypertension could be prevented with elimination of high salt intake. Salt IntakeDiseaseNo DiseaseTotalIncidence (I) (I) per 1,000 _______ Exposed _______ Not Exposed _______ Total _______ PAR%_______ PAR% = (I total – I nonexposed ) / I total PAR% =

Practice – Population Attributable Risk% (PAR%) Hypertension Estimate the percentage of the burden of hypertension among Tampanians that is attributed to high salt consumption. In TAMPA, 21% of the cases of hypertension may be attributed to having high salt consumption in the population. In TAMPA, 21% of the cases of hypertension could be prevented with elimination of high salt intake. Salt IntakeDiseaseNo DiseaseTotalIncidence (I) (I) per 1, /1, /1, /1,000 Exposed Not Exposed Total PAR%21.0% PAR% = (I total – I nonexposed ) / I total PAR% = (0.064 – 0.051) / = / = 21.0%

Measures of Public Health Impact NOTE! Both attributable and population attributable risks should be cautiously interpreted. In reality, even if an exposure is causal, we do not know whether it truly contributed to disease occurrence in all exposed persons - - in some exposed persons, other causal factors may have been entirely responsible.

SECTION 7.9 Attributable Risk and Population Attributable Risk Percent for Case- Control Studies

Learning Outcome: Calculate and interpret the measures attributable risk (AR) and attributable risk percent (AR%) in Case Control Studies

l They are based on measures of incidence. l We can calculate incidence measures from case-control studies only under special circumstances. l Therefore, the AR and PAR cannot usually be calculated from case-control data. l However, for most case-control studies, we can calculate the AR% and PAR%. Measures of Public Health Impact

AR% (Case-Control Studies) (OR – 1) AR% = x100 OR

Example: AR% (Case-Control Studies) SmokeYesNo Yes No90200 Case-control study to evaluate the impact of smoking as related to bladder cancer. Bladder Cancer (160 / 90) OR = (120 / 200) = 2.96

Example: AR% (Case-Control Studies) Question: Among smokers, what proportion (percent) of bladder cancer cases can be attributed to their smoking habit? (OR – 1) AR% = x100 OR AR% =((2.96 – 1) / 2.96) x 100 = 66.2%

Example: AR% (Case-Control Studies) l 66% of bladder cancer cases among smokers can be attributed to their smoking. l 66% of bladder cancer cases among smokers could be prevented if they had never taken up smoking. (Assuming there is a causal association between smoking and the development of bladder cancer).

Practice: AR% (Case-Control Studies) Esophageal Cancer Among smokers, estimate the percentage of esophageal cancer cases attributed to smoking. Among smokers, SmokingDiseaseNo DiseaseTotal Smoker Non-smoker OR_______ AR% _______ (OR – 1) AR% = x 100AR = x 100= _______ OR OR = _____________

Esophageal Cancer Among smokers, 66% of esophageal cancer cases can be attributed to their smoking. Among smokers, 66% of esophageal cancer cases could be prevented if they had never taken up smoking. SmokingDiseaseNo DiseaseTotal Smoker Non-smoker OR1.692 AR% 40.9% (OR – 1)(1.692 – 1) AR% = x 100AR = x 100=40.9% OR OR = (65/288) / (52/396) = Practice: AR% (Case-Control Studies) Among smokers, estimate the percentage of esophageal cancer cases attributed to smoking.

PAR% (Case-Control Studies) (P E ) (OR – 1) PAR% = x 100 [(P E ) (OR-1)] + 1 where P E = proportion of exposed controls (assuming that the proportion of exposed controls is representative of the proportion exposed in the source population)

Example: PAR% (Case-Control Studies) SmokeYesNo Yes No90200 Case-control study to evaluate the impact of smoking as related to bladder cancer. Bladder Cancer (160 / 90) OR = (120 / 200) = 2.96 P E = 120 / 320 = 0.375

Example: PAR% (Case-Control Studies) Question: In this study population, what proportion (percent) of bladder cancer cases can be attributed to smoking? (P E ) (OR – 1) PAR% = x 100 [(P E ) (OR-1)] + 1 PAR% = (0.375) (2.96-1) [(0.375) (2.96-1)] + 1 x 100 = 42.4%

Example: PAR% (Case-Control Studies) l In this study population, 42% of bladder cancer cases can be attributed to smoking. l In this study population, 42% of bladder cancer cases could be prevented if people would not take up smoking. (Assuming there is a causal association between smoking and the development of bladder cancer).

Practice: PAR% (Case-Control Studies) Esophageal Cancer Among the study population, estimate the percentage of esophageal cancer cases attributed to smoking. In this study population, SmokingDiseaseNo DiseaseTotal Smoker Non-smoker OR_______ PE PE PAR% _______ PAR% = x 100PAR%=______________ OR = _____________ P E = _____________ (P E ) (OR – 1) PAR% = x 100 [(P E ) (OR-1)] + 1

Practice: PAR% (Case-Control Studies) Esophageal Cancer Among the study population, estimate the percentage of esophageal cancer cases attributed to smoking. SmokingDiseaseNo DiseaseTotal Smoker Non-smoker OR_______ PE PE PAR% _______ x (1.692 – 1) PAR% = x 100PAR% = 7.4% [(0.116) ( )] + 1 OR = (65 / 266) / (52 / 396) = P E = 52 / ( ) = (P E ) (OR – 1) PAR% = x 100 [(P E ) (OR-1)] + 1 In this study population, 7.4% of esophageal cancer cases can be attributed to smoking. In this study population, 7.4% of esophageal cancer cases could be prevented if people would not take up smoking.

SECTION 7.10 Attributable Risk versus Relative Risk

Learning Outcome: Differentiate between attributable risk and relative risk.

Relative Risk vs. Attributable Risk Smokers Non- smokersRRARAR% Lung cancer CHD Age-Adjusted Death Rates per 100,000

Relative Risk vs. Attributable Risk Smokers Non- smokers RRARAR% Lung cancer CHD Smoking has a much stronger association with lung cancer mortality than CHD mortality, however… death from CHD is much more common than lung cancer, hence higher attributable risk associated with smoking.

Issues in Prevention Policy An important question in prevention is whether the approach should target specific groups known to be at high risk, or extend to the general population as a whole. This depends largely on the nature of the exposure/disease relationship, and the distribution of the exposure in the population.

Percent of population Systolic Blood Pressure (mm Hg) The majority of the population has systolic blood pressure values in the normal range (< 140).

RR of CHD Death Systolic Blood Pressure (mm Hg) The risk of CHD increases steadily with higher systolic blood pressure levels.

% of excess CHD deaths Systolic Blood Pressure (mm Hg) The majority of excess CHD deaths occur largely in the high-normal range (130 to 159).

SECTION 7.11 Number Need to Treat

Learning Outcome: Calculate and interpret the measure Number Needed to Treat (NNT).

“Number Needed to Treat” Example: Assume: Treatment A = Drug Treatment B = Placebo Outcome = Colon Cancer within 5 Year Incidence A =0.15 Incidence B =0.20 NNT =1 / (I B – I A ) =1 / (0.20 – 0.15) =20 treated

Cannon (2006) No difference was observed for total or non-cardiovascular mortality………… – 28.8 = 3.5

Treating to New Targets (TNT) study Any Cardiovascular Event: Atorvastatin – 10 mg: Atorvastatin – 80 mg: Number Needed to Treat (NNT) NNT = 1 / (Incidence 10mg – Incidence 80mg ) = 18.5 Major Cardiovascular Event: Atorvastatin – 10 mg: Atorvastatin – 80 mg: NNT = 45.5 This is the best case scenario…….(e.g. initial run-in phase for trial eligibility).

Practice: Number Needed to Treat (NNT) Assume that a new type of immunotherapy, which is expensive, is more effective in treating ulcerative colitis compared to standard of care therapy. Calculate the number needed to treat to avoid a recurrence of disease with the more expensive new immunotherapy. Assume: Treatment A = New Immunotherapy Treatment B = Standard of Care Outcome = Recurrence of Ulcerative Colitis within 5 years Incidence A =0.20 Incidence B =0.35 NNT =1 / (I B – I A ) =_________ =______ treated patients

Practice: Number Needed to Treat (NNT) Assume that a new type of immunotherapy, which is expensive, is more effective in treating ulcerative colitis compared to standard of care therapy. Calculate the number needed to treat to avoid a recurrence of disease with the more expensive new immunotherapy. Assume: Treatment A = New Immunotherapy Treatment B = Standard of Care Outcome = Recurrence of Ulcerative Colitis within 5 years Incidence A =0.20 Incidence B =0.35 NNT =1 / (I B – I A ) =1 / (0.35 – 0.20) =6.7 (rounded up to 7) = treated patients